Tenax Therapeutics Statistics
Total Valuation
TENX has a market cap or net worth of $657.04 million. The enterprise value is $519.89 million.
| Market Cap | 657.04M |
| Enterprise Value | 519.89M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TENX has 51.09 million shares outstanding. The number of shares has increased by 71.60% in one year.
| Current Share Class | 26.53M |
| Shares Outstanding | 51.09M |
| Shares Change (YoY) | +71.60% |
| Shares Change (QoQ) | +10.53% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 39.61% |
| Float | 26.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.51 |
| P/TBV Ratio | 5.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.52
| Current Ratio | 14.52 |
| Quick Ratio | 13.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.71% and return on invested capital (ROIC) is -34.39%.
| Return on Equity (ROE) | -51.71% |
| Return on Assets (ROA) | -32.74% |
| Return on Invested Capital (ROIC) | -34.39% |
| Return on Capital Employed (ROCE) | -53.73% |
| Weighted Average Cost of Capital (WACC) | 9.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.62M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +121.12% in the last 52 weeks. The beta is 0.96, so TENX's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +121.12% |
| 50-Day Moving Average | 12.32 |
| 200-Day Moving Average | 11.18 |
| Relative Strength Index (RSI) | 56.69 |
| Average Volume (20 Days) | 955,155 |
Short Selling Information
The latest short interest is 792,041, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 792,041 |
| Short Previous Month | 775,851 |
| Short % of Shares Out | 1.55% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 1.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -61.62M |
| Pretax Income | -57.91M |
| Net Income | -57.91M |
| EBITDA | n/a |
| EBIT | -61.62M |
| Earnings Per Share (EPS) | -$1.40 |
Balance Sheet
The company has $118.76 million in cash and n/a in debt, with a net cash position of $118.76 million or $2.32 per share.
| Cash & Cash Equivalents | 118.76M |
| Total Debt | n/a |
| Net Cash | 118.76M |
| Net Cash Per Share | $2.32 |
| Equity (Book Value) | 114.69M |
| Book Value Per Share | 2.35 |
| Working Capital | 114.69M |
Cash Flow
| Operating Cash Flow | -38.14M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -38.14M |
| FCF Per Share | -$0.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.60% |
| Shareholder Yield | -71.60% |
| Earnings Yield | -9.07% |
| FCF Yield | -5.97% |
Analyst Forecast
The average price target for TENX is $33.88, which is 163.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.88 |
| Price Target Difference | 163.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.
| Last Split Date | Jan 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |